Now PlayingEP. 1 The Evolution of Treatment Paradigms in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
EP. 4 Treatment Approaches for Patients with mCRPC and Bone-Only Disease Progression After Radiotherapy
EP. 9 Symptomatic Status and Lesion Size of Bone Metastases: Impact on Radiotherapy Selection in mCRPC
November 15th, 2026Five Under 5: Top Oncology Videos for the Week of 11/8The top 5 OncLive TV videos of the week cover insights in HER2+ breast cancer, NSCLC, ovarian cancer, prostate cancer, and sarcoma.Read more
November 12th, 2026FDA Grants Breakthrough Therapy Designation to 64Cu-SAR-bisPSMA for PSMA PET in Biochemically Recurrent Prostate CancerPhase 2 Co-PSMA data showed higher lesion detection with 64Cu-SAR-bisPSMA vs 68Ga-PSMA-11 in biochemical recurrence after prostatectomy.Read more
November 10th, 2026Genomic Testing, Toxicity, and Sequencing Shape Treatment Decisions in Advanced Prostate CancerExperts weigh genomic testing, treatment intensification, and radioligand sequencing in advanced prostate cancer care.Read more